Bamide Diguibe Tien-Bale, Adoli Latame Komla, Agossoukpe Sêdégnon Benoît, Togan Roméo Mèdéssè, Tognon Hermine, Simpore Ismaël, Soubeiga Dieudonné
Institute for Interdisciplinary Training and Research in Health and Education Sciences (IFRISSE), Ouagadougou, Burkina Faso.
Department of Public Health, Faculty of Health Sciences, University of Lomé, Togo.
Am J Mens Health. 2025 May-Jun;19(3):15579883251344558. doi: 10.1177/15579883251344558. Epub 2025 Jun 25.
Prostate cancer is the leading male cancer in sub-Saharan Africa, with 74,878 (17.4%) new cases and 32,390 (11.6%) deaths in 2022. In Togo, the total number of prostate cancers was 726 in 2021. Screening methods are readily available in Togo. However, prostate cancer is still detected at a late stage. This study aimed to determine the factors associated with adherence to prostate cancer screening among retired men in Togo, 2023, using the Health Belief Model. A national descriptive and analytical exploratory cross-sectional study was carried out from March 1 to May 31, 2023. A total of 288 retirees were included. Overall, 54.9% of retirees perceived their vulnerability to prostate cancer, 54.9% perceived its severity, 52.4% perceived barriers to screening, 50.3% perceived benefits from screening, 53.1% perceived their self-efficacy for screening, and 55.2% perceived cues to action. A total of 83% of retirees agreed to undergo prostate cancer screening. The absence of a history of chronic pathology (adjust odds ratio [aOR] = 3.0, 95% CI [1.4, 6.2], = .010), frequency of annual medical consultation (aOR = 0.3, 95% CI [0.1, 0.8], = .020), perceived obstacles (aOR = 0.4, 95% CI [0.2, 0.9], = .029) and perceived cues to action (aOR = 5.1, 95% CI [1.9, 15.1], = .002) are significantly associated with adherence to prostate cancer screening. This study reported a high level of adherence to prostate cancer screening among retirees. It demonstrated that the absence of a history of chronic pathology, frequency of annual medical consultation, perceived barriers, and perceived incentive to action were significantly associated with adherence to prostate cancer screening.
前列腺癌是撒哈拉以南非洲地区最主要的男性癌症，2022年有74878例新发病例（占17.4%），32390例死亡病例（占11.6%）。在多哥，2021年前列腺癌病例总数为726例。多哥有现成的筛查方法。然而，前列腺癌仍在晚期才被发现。本研究旨在运用健康信念模型确定2023年多哥退休男性中与坚持前列腺癌筛查相关的因素。2023年3月1日至5月31日开展了一项全国性描述性和分析性探索性横断面研究。共纳入288名退休人员。总体而言，54.9%的退休人员认为自己易患前列腺癌，54.9%的人认为其严重性，52.4%的人认为存在筛查障碍，50.3%的人认为筛查有益，53.1%的人认为自己有筛查的自我效能感，55.2%的人认为有行动提示。共有83%的退休人员同意接受前列腺癌筛查。无慢性病史（调整优势比[aOR]=3.0，95%置信区间[CI][1.4, 6.2]，P=.010）、年度体检频率（aOR=0.3，95% CI[0.1, 0.8]，P=.020）、感知障碍（aOR=0.4，95% CI[0.2, 0.9]，P=.029）和感知行动提示（aOR=5.1，95% CI[1.9, 15.1]，P=.002）与坚持前列腺癌筛查显著相关。本研究报告退休人员对前列腺癌筛查的依从性较高。研究表明，无慢性病史、年度体检频率、感知障碍和感知行动动机与坚持前列腺癌筛查显著相关。
